Respiratorius AB (publ) (XSAT:RESP)
2.280
0.00 (0.00%)
At close: Aug 26, 2026
Respiratorius AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Apr '22 Apr 30, 2022 |
Cash & Equivalents | 2.93 | 7.36 | 7.65 | 1.95 | 7.55 | 57.33 |
Cash & Short-Term Investments | 2.93 | 7.36 | 7.65 | 1.95 | 7.55 | 57.33 |
Cash Growth | -6.42% | -3.76% | 292.28% | -74.20% | -86.82% | 107.02% |
Other Receivables | - | 0.15 | 0.06 | 0.07 | 0.52 | 0.27 |
Receivables | - | 0.15 | 0.06 | 0.07 | 0.52 | 0.27 |
Prepaid Expenses | - | 0.14 | 0.27 | 0.18 | 0.16 | 0.33 |
Total Current Assets | 3.2 | 7.65 | 7.97 | 2.2 | 8.24 | 57.93 |
Other Intangible Assets | 24.17 | 2.51 | 2.63 | 2.54 | 2.29 | 4.23 |
Long-Term Deferred Charges | - | 21.76 | 20.42 | 23.04 | 25.22 | 42.33 |
Other Long-Term Assets | -0 | - | - | - | - | - |
Total Assets | 27.37 | 31.92 | 31.02 | 27.77 | 35.75 | 104.49 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Apr '22 Apr 30, 2022 |
Accounts Payable | - | 1.06 | 0.56 | 0.34 | 0.44 | 10.89 |
Accrued Expenses | - | 0.21 | 0.33 | 0.93 | 0.51 | 1 |
Other Current Liabilities | 0.27 | 0.04 | 0.04 | - | 0.48 | 0.05 |
Total Current Liabilities | 0.27 | 1.31 | 0.92 | 1.27 | 1.42 | 11.94 |
Total Liabilities | 0.27 | 1.31 | 0.92 | 1.27 | 1.42 | 11.94 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Apr '22 Apr 30, 2022 |
Common Stock | 23.71 | 23.71 | 15.3 | 14.62 | 14.62 | 14.62 |
Additional Paid-In Capital | - | - | - | - | 81.2 | 130.85 |
Comprehensive Income & Other | - | 6.9 | 14.8 | 11.89 | -61.49 | -52.91 |
Shareholders' Equity | 27.1 | 30.61 | 30.1 | 26.5 | 34.33 | 92.56 |
Total Liabilities & Equity | 27.37 | 31.92 | 31.02 | 27.77 | 35.75 | 104.49 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Apr '22 Apr 30, 2022 |
Net Cash (Debt) | 2.93 | 7.36 | 7.65 | 1.95 | 7.55 | 57.33 |
Net Cash Growth | -6.42% | -3.76% | 292.28% | -74.20% | -86.82% | 107.02% |
Net Cash Per Share | 0.40 | 1.24 | 1.91 | 0.67 | - | - |
Filing Date Shares Outstanding | 7.9 | 7.9 | 5.1 | 2.92 | 2.92 | 2.92 |
Total Common Shares Outstanding | 7.9 | 7.9 | 5.1 | 2.92 | 2.92 | 2.92 |
Working Capital | 2.92 | 6.34 | 7.05 | 0.93 | 6.82 | 45.99 |
Book Value Per Share | 3.43 | 3.87 | 5.90 | 9.07 | 11.74 | 31.66 |
Tangible Book Value | 2.92 | 28.09 | 27.47 | 23.97 | 32.04 | 88.32 |
Tangible Book Value Per Share | 0.37 | 3.56 | 5.39 | 8.20 | 10.96 | 30.21 |